📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England (2022)

First Author: Tan Y

Attributed to: COVID-19 Longitudinal Health and Wellbeing - National Core Study (LWH-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2666-7568(22)00186-6

PubMed Identifier: 36150402

Publication URI: http://europepmc.org/abstract/MED/36150402

Type: Journal Article/Review

Parent Publication: The Lancet Healthy Longevity

Issue: 10

ISSN: 2666-7568